Substance / Medication

Acamprosate calcium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

116 trials linked to this intervention

116
Total Trials
19
Recruiting
46
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Pharmacokinetics and bioequivalence evaluation of acamprosate calcium tablets in healthy Chinese volunteers.
Luo Zhu, Shen Yali, Liang Maozhi et al. · Eur J Pharm Sci · 2015
PMID: 26360834RCT
Pharmacokinetics of acamprosate calcium in healthy Chinese subjects after oral administration of three dosage levels.
Xu Fan, Qing Yongping, Shang Beicheng et al. · Arzneimittelforschung · 2009
PMID: 20108648RCT
Acamprosate calcium as augmentation therapy for anxiety disorders.
Schwartz Thomas L, Siddiqui Umar A, Raza Shafi et al. · Ann Pharmacother · 2010
PMID: 21062908Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Acamprosate calcium (substance)
SNOMED CT
391699001
UMLS CUI
C0592789

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
116
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.